Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Safety and Efficacy of Cordimax and Xience V Drug-eluting Stents, for the Treatment of Coronary Heart Disease (CHD) in the Clinical Research of Real World

NCT03185221 is registered in ClinicalTrials.gov with Shandong Branden Med.Device Co.,Ltd as lead sponsor.

NCT NCT03185221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03185221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Safety and Efficacy of Cordimax and Xience V Drug-eluting Stents, for the Treatment of Coronary Heart Disease (CHD) in the Clinical Research of Real World
Lead sponsor
Shandong Branden Med.Device Co.,Ltd
Phase
Phase 3
Overall status
Unknown status
Start date
June 20, 2013
Completion date
June 20, 2020
Enrollment
3,660 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery stenosis